The anti-apoptotic protein Bcl-2 presented absent or low staining in the majority of the cases (75.0% (12 out of 16 cases)), and significantly associated with smaller tumor size (6.86 ± 0.72 vs. 11.50 ± 1.76, p = 0.011, Figure 2B), Table 2. Here, BCL2 is linked to neoplasm.